| Title |
ERK2, but Not ERK1, Mediates Acquired and “De novo” Resistance to Imatinib Mesylate: Implication for CML Therapy
|
|---|---|
| Published in |
PLOS ONE, July 2009
|
| DOI | 10.1371/journal.pone.0006124 |
| Pubmed ID | |
| Authors |
Clara I. Aceves-Luquero, Anupriya Agarwal, Juan L. Callejas-Valera, Laura Arias-González, Azucena Esparís-Ogando, Luis del Peso Ovalle, Itxaso Bellón-Echeverria, Miguel A. de la Cruz-Morcillo, Eva M. Galán Moya, Inmaculada Moreno Gimeno, Juan C. Gómez, Michael W. Deininger, Atanasio Pandiella, Ricardo Sánchez Prieto |
Mendeley readers
The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Poland | 1 | 3% |
| Czechia | 1 | 3% |
| Canada | 1 | 3% |
| Unknown | 37 | 93% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 12 | 30% |
| Student > Ph. D. Student | 7 | 18% |
| Professor > Associate Professor | 5 | 13% |
| Student > Master | 3 | 8% |
| Student > Bachelor | 2 | 5% |
| Other | 5 | 13% |
| Unknown | 6 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 10 | 25% |
| Agricultural and Biological Sciences | 10 | 25% |
| Medicine and Dentistry | 7 | 18% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
| Mathematics | 1 | 3% |
| Other | 5 | 13% |
| Unknown | 5 | 13% |